You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (90)

Journals (0)

1-10 of 90 results for anaplastic lymphoma kinase inhibitors

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Acute kidney Injury due to Alectinib,an Anaplastic Lymphoma Kinase inhibitor

Retricted access

Case report

First published 2021-2

Acute kidney Injury due to Alectinib,an Anaplastic Lymphoma Kinase inhibitor

Chin Lin Ng, Alaeldin Abdalla, Greta Galambosi [...]

Journal of Onco-Nephrology

Select article: Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers

Retricted access

Research article

First published 2022-08

Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers

Mohd Adnan, Saadgee Koli, Taj Mohammad [...]

OMICS: A Journal of Integrative Biology

Select article: Life-threatening hypertriglyceridemia-induced pancreatitis related to alectinib successfully treated by plasmapheresis: A review of the literature on metabolic toxicities associated with anaplastic lymphoma kinase inhibitors

Retricted access

Case report

First published 2020-9

Life-threatening hypertriglyceridemia-induced pancreatitis related to alectinib successfully treated by plasmapheresis: A review of the literature on metabolic toxicities associated with anaplastic lymphoma kinase inhibitors

Arundati Rao, Aswanth Reddy, Corey Dinunno [...]

Journal of Oncology Pharmacy Practice

Select article: Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancer

Retricted access

Case report

First published 2019-9

Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancer

Andrew Hwang, Andrew Iskandar, Constantin A Dasanu

Journal of Oncology Pharmacy Practice

Select article: The potential for crizotinib in non-small cell lung cancer: a perspective review

Free access

Review article

First published 2011-11

The potential for crizotinib in non-small cell lung cancer: a perspective review

Yung-Jue Bang

Therapeutic Advances in Medical Oncology

Select article: Economic burden in patients with anaplastic lymphoma kinase ( ALK )-positive non-small cell lung cancer (NSCLC),with or without brain metastases,receiving first-line ALK inhibitors

Open access

Research article

First published 2023-9

Economic burden in patients with anaplastic lymphoma kinase ( ALK )-positive non-small cell lung cancer (NSCLC),with or without brain metastases,receiving first-line ALK inhibitors

Yanyu Wu, Kaili Ren, Yin Wan [...]

Journal of Oncology Pharmacy Practice

Select article: Newer biological agents: CAR T cells,PARP inhibitors,and ALK inhibitors

Retricted access

Research article

First published 2019-6

Newer biological agents: CAR T cells,PARP inhibitors,and ALK inhibitors

Journal of Onco-Nephrology

Select article: Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer

Retricted access

Research article

First published 2021-2

Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer

Emily Miao, Nagashree Seetharamu, Kevin Sullivan [...]

Journal of Pharmacy Practice

Select article: Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study

Open access

Research article

First published 2024

Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study

Rawan Dawoud, Harman Saman, Kakil Rasul [...]

Clinical Medicine Insights: Oncology

Select article: Anaplastic lymphoma kinase rearrangements in patients with non-small cell lung cancer in Jordan

Open access

Research article

First published 2022-6

Anaplastic lymphoma kinase rearrangements in patients with non-small cell lung cancer in Jordan

Bayan Maraqa, Maxim Al-Ashhab, Maher A. Sughayer

Journal of International Medical Research

1
2
3
•••
9
10 / page

Article type

Publication date

Subjects

Access